Related Experiment Video
Updated: Jun 22, 2026
16:04
A Tetracycline-regulated Cell Line Produces High-titer Lentiviral Vectors that Specifically Target Dendritic Cells
Published on: June 19, 2013
Immunity of lentiviral vector-modified dendritic cells
1Department of Molecular Genetics and Microbiology, Powell Gene Therapy Center and McKnight Brain Institute, University of Florida, College of Medicine, Gainesville, FL, USA.
Methods in Molecular Biology (Clifton, N.J.)
|July 2, 2009
Summary
Engineering dendritic cells (DCs) using lentiviral vectors (LVs) can restore immune function in patients. This approach generates fully functional DCs to enhance immunotherapy success by overcoming immune dysfunction.
Area of Science:
- Immunology
- Cell Biology
- Biotechnology
Background:
- Dendritic cells (DCs) are crucial antigen-presenting cells (APCs) for initiating and regulating immune responses.
- Immune-compromised patients often have immature DCs with impaired functions, hindering effective immunotherapy.
- Engineering DCs in vitro offers a promising strategy to overcome these limitations and restore host immunity.
Purpose of the Study:
- To highlight the importance of engineering antigen-specific DCs for improving immunotherapy.
- To present lentiviral vectors (LVs) as efficient tools for modifying DC functions.
- To discuss functional assays for evaluating engineered DC-mediated immune responses.
Main Methods:
- Utilizing lentiviral vectors (LVs) for gene transfer into DCs or their progenitors.
- Engineering DCs in vitro to restore or enhance their functional capacity.
- Employing functional assays to analyze the immune cell response.
Main Results:
- Lentiviral vectors (LVs) demonstrate high efficiency in engineering DC functions.
- Engineered DCs can potentially overcome immune dysfunction in patients.
- The chapter provides examples of LVs and assays for assessing effector immune cell responses.
Conclusions:
- Engineering antigen-specific DCs is a vital approach to enhance immunotherapy.
- Lentiviral vectors (LVs) are effective tools for DC modification.
- This strategy holds significant potential for treating immune dysfunction and improving patient outcomes.
